Skip to main content
Advertising

Originally published November 30, 2012 at 3:08 PM | Page modified November 30, 2012 at 3:08 PM

  • Share:
             
  • Comments (0)
  • Print

Biotech company closing Bothell site

Drug-discovery activities will be transferred to AMRI facilities in Singapore and its hometown of Albany, N.Y.

By Seattle Times Business staff

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

New York-based biotechnology researcher AMRI is closing its Bothell site, eliminating 24 jobs.

The company said Friday its drug-discovery activities will be transferred to AMRI facilities in Singapore and its hometown of Albany, N.Y.

AMRI acquired the Bothell operation in 2001. It moved into a 44,000-square-foot facility in 2009 with expectations it would “double the scale of the current operation over the next five years,” according to a company filing at the time.

AMRI, which provides contract research and development services to biotech and pharmaceutical companies, reported losses in four of the past five quarters and recently closed a research site in Hungary that had employed 100.

The Bothell closure will be complete by March 2013. After one-time charges of about $11 million, the closure will save about $2 million a year, AMRI said.

News where, when and how you want it

Email Icon

Relive the magic

Relive the magic

Shop for unique souvenirs highlighting great sports moments in Seattle history.

Advertising

Advertising

NDN Video

Advertising